Topiramate therapy for symptomatic trigeminal neuralgia

Clinical Drug Investigation

Volumn 26, Issue 2, 2006, Pages 113-115

  Siniscalchi, A ^a   Gallelli, L ^b   Scornaienghi, D ^a   Mancuso, F ^a   De Sarro, G ^b  

^a 'Annunziata' Hospital   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; GABAPENTIN; TOPIRAMATE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DRUG SAFETY; FEMALE; HUMAN; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; PAIN ASSESSMENT; PRIORITY JOURNAL; SOMNOLENCE; TREATMENT OUTCOME; TRIGEMINUS NEURALGIA;

ANTICONVULSANTS; FEMALE; FRUCTOSE; HUMANS; MIDDLE AGED; MULTIPLE SCLEROSIS; RECEPTORS, AMPA; TRIGEMINAL NEURALGIA;

EID: 33244477648     PISSN: 11732563     EISSN: 11732563     Source Type: Journal    
DOI: 10.2165/00044011-200626020-00006     Document Type: Article

References (22)

1. Crayton H, Heyman RA, Rosmann HS. A multimodal approach to managing the symptoms of multiple sclerosis. Neurology 2004; 63: S12-8
2. Tomson T, Tybring G, Bertilsson L, et al. Carbamazepine therapy in trigeminal neuralgia: clinical effects in relation to plasma concentration. Arch Neurol 1980; 37: 699-703
3. Tomson T, Bertilsson L. Potent therapeutic effect of carbamazepine-10,11- epoxide in trigeminal neuralgia. Arch Neurol 1984; 41: 588-601
4. Cheshire WP. Trigeminal neuralgia: a guide to drug choice. CNS Drugs 1997; 7: 98-110
5. Sindrup SH, Jensen TS. Pharmacotherapy of trigeminal neuralgia. Clin J Pain 2002; 18: 22-7
6. Peiris JB, Perera GLS, Devendra SV, et al. Sodium valproate in trigeminal neuralgia [letter]. Med J Aust 1980; 2: 278
7. Desai N, Shah K, Gandhi I. Baclofen sodium valproate combination in carbamazepine resistant trigeminal neuralgia: a double blind clinical trial. Cephalalgia 1991; 11 Suppl. 11: 321-2
8. Zakrzewska JM, Chaudhry Z, Nurmikko TJ, et al. Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain 1997; 73: 223-30
9. Khan OA. Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients. Neurology 1998; 51: 611-4
10. Zvartau-Hind M, Din MU, Gilani A, et al. Topiramate relieves refractory trigeminal neuralgia in MS patients. Neurology 2000; 55: 1587-8
11. Spina E, Perugi G. Antiepileptic drugs: indications other than epilepsy. Epileptic Disord 2004; 6: 57-65
12. Jensen MP, Turner JA, Romano JM. What is the maximum number of levels needed in pain intensity measurement? Pain 1994; 58: 387-92
13. Berthier F, Potel G, Leconte P, et al. Comparative study of methods of measuring acute pain intensity in an ED. Am J Emerg Med 1998; 16: 132-6
14. Perucca E. An introduction to antiepileptic drugs. Epilepsia 2005; 46: 31-7
15. Gilron I, Booher SL, Rowan JS, et al. Topiramate in trigeminal neuralgia: a randomized, placebo-controlled multiple crossover pilot study. Clin Neuropharmacol 2001; 24 (2): 109-12
16. Burchiel KJ. Abnormal impulse generation in focally demyelinated trigeminal roots. J Neurosurg 1980; 53: 674-83
17. Sakurai M, Kanazawa I. Positive symptoms in multiple sclerosis: their treatment with sodium channel blockers, lidocaine and mexiletine. J Neurol Sci 1999; 15: 162-8
18. Solaro C, Lunardi GL, Capello E, et al. An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients. Neurology 1998; 51: 609-11
19. Russo E, Constanti A, Ferreri G, et al. Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy. Neuropharmacology 2004; 46: 865-78
20. Tidwell A, Swims M. Review of the newer antiepileptic drugs. Am J Manag Care 2003; 9: 253-76
21. Nieto-Barrera M. Characteristics and indications of topiramate. Rev Neurol 2002; 35 Suppl. 1: S88-95
22. Bialer M, Doose DR, Murthy B, et al. Pharmacokinetic interactions of topiramate. Clin Pharmacokinet 2004; 43: 763-80